{"DataElement":{"publicId":"2922104","version":"1","preferredName":"Acquired Immunodeficiency Syndrome Immune Stage","preferredDefinition":"Numeric value to represent the extent of the deficiency of cellular immunity caused by the human immunodeficiency virus (HIV) as characterized by change in CD4 count.","longName":"AIDS_IMM_STG","context":"CCR","contextVersion":"1","DataElementConcept":{"publicId":"2921045","version":"1","preferredName":"Acquired Immunodeficiency Syndrome Immune Stage","preferredDefinition":"A syndrome resulting from the acquired deficiency of cellular immunity caused by the human immunodeficiency virus (HIV).  It is characterized by the reduction of the Helper T-lymphocytes in the peripheral blood and the lymph nodes.  Symptoms include generalized lymphadenopathy, fever, weight loss, and chronic diarrhea.  Patients with AIDS are especially susceptible to opportunistic infections (usually pneumocystis carinii pneumonia, cytomegalovirus (CMV) infections, tuberculosis, candida infections, and cryptococcosis), and the development of malignant neoplasms (usually non-Hodgkin's lymphoma and Kaposi's sarcoma).  The human immunodeficiency virus is transmitted through sexual contact, sharing of contaminated needles, or transfusion of contaminated blood. -- 2004__Protected against infectious disease by either specific or non-specific mechanisms._The extent of a cancer within the body, especially whether the disease has spread from the original site to other parts of the body.","longName":"AIDS_IMM_STG","context":"CCR","contextVersion":"1","ObjectClass":{"publicId":"2542204","version":"1","preferredName":"Acquired Immunodeficiency Syndrome","preferredDefinition":"A syndrome resulting from the acquired deficiency of cellular immunity caused by the human immunodeficiency virus (HIV). It is characterized by the reduction of the Helper T-lymphocytes in the peripheral blood and the lymph nodes; opportunistic infections (usually pneumocystis carinii pneumonia, cytomegalovirus (CMV) infections, tuberculosis, candida infections, and cryptococcosis); and the development of malignant neoplasms (usually non-Hodgkin's lymphoma and Kaposi's sarcoma). The human immunodeficiency virus is transmitted through sexual contact, sharing of contaminated needles, or transfusion of contaminated blood. Generalized lymphadenopathy, fever, weight loss, and chronic diarrhea are common symptoms of AIDS. The patients usually die either of opportunistic infections or malignant neoplasms. -- 2004","longName":"C2851","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Acquired Immunodeficiency Syndrome","conceptCode":"C2851","definition":"A syndrome resulting from the acquired deficiency of cellular immunity caused by the human immunodeficiency virus (HIV). It is characterized by the reduction of the Helper T-lymphocytes in the peripheral blood and the lymph nodes. Symptoms include generalized lymphadenopathy, fever, weight loss, and chronic diarrhea. Patients with AIDS are especially susceptible to opportunistic infections, tuberculosis, candida infections, and cryptococcosis), and the development of malignant neoplasms (usually non-Hodgkin lymphoma and Kaposi sarcoma). The human immunodeficiency virus is transmitted through sexual contact, sharing of contaminated needles, or transfusion of contaminated blood.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":"NCI Thesaurus","workflowStatus":"RELEASED","registrationStatus":"Application","id":"224D2D65-6714-4AEB-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2006-11-15","endDate":null,"createdBy":"SHIDED","dateCreated":"2006-11-15","modifiedBy":"ONEDATA","dateModified":"2006-11-15","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"Property":{"publicId":"2921043","version":"1","preferredName":"Immune Stage","preferredDefinition":"Protected against infectious disease by either specific or non-specific mechanisms. (On-line Medical Dictionary):The extent of a cancer within the body, especially whether the disease has spread from the original site to other parts of the body.","longName":"C17997:C16899","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Immune","conceptCode":"C17997","definition":"Protected against infectious disease by either specific or non-specific mechanisms.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Neoplasm Stage","conceptCode":"C16899","definition":"The extent of a cancer in the body.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"6F363335-2E7D-482D-E040-BB89AD434EEA","latestVersionIndicator":"Yes","beginDate":"2009-07-21","endDate":null,"createdBy":"REEVESD","dateCreated":"2009-07-21","modifiedBy":"ONEDATA","dateModified":"2009-07-21","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ConceptualDomain":{"publicId":"2008549","version":"1","preferredName":"Involvement and Extent of Disease","preferredDefinition":"indication of the presence and extent of disease.","longName":"INV_AND_EXT_OF_DZ","context":"CTEP","contextVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B22AA815-A017-5261-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2002-12-19","endDate":null,"createdBy":"MSUPLEY","dateCreated":"2002-12-19","modifiedBy":"SBR","dateModified":"2003-10-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"6F363A70-C1C0-668A-E040-BB89AD43602E","latestVersionIndicator":"Yes","beginDate":"2009-07-21","endDate":null,"createdBy":"REEVESD","dateCreated":"2009-07-21","modifiedBy":"SBR","dateModified":"2016-06-06","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ValueDomain":{"publicId":"2921057","version":"1","preferredName":"Acquired Immunodeficiency Syndrome Immune Stage","preferredDefinition":"An acquired defect in immune system function caused by human immunodeficiency virus (HIV).  AIDS is associated with increased susceptibility to certain cancers and to opportunistic infections, which are infections that occur rarely except in individuals with weak immune systems._Protected against infectious disease by either specific or non-specific mechanisms. (On-line Medical Dictionary)_The extent of a cancer within the body, especially whether the disease has spread from the original site to other parts of the body.","longName":"AIDS_IMM_STG","context":"CCR","contextVersion":"1","type":"Enumerated","dataType":"CHARACTER","minLength":"1","maxLength":"1","minValue":null,"maxValue":null,"decimalPlace":null,"PermissibleValues":[{"value":"1","valueDescription":"1 - CD4 cells <200 cells per cubic millimeter","ValueMeaning":{"publicId":"2921058","version":"1","preferredName":"1 - CD4 cells <200 cells per cubic millimeter","longName":"2921058","preferredDefinition":"CD4 cells less than 200 cells per cubic millimiter","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"6F363A70-C2F9-668A-E040-BB89AD43602E","latestVersionIndicator":"Yes","beginDate":"2009-07-21","endDate":null,"createdBy":"REEVESD","dateCreated":"2009-07-21","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"6F363A70-C312-668A-E040-BB89AD43602E","beginDate":"2009-07-21","endDate":null,"createdBy":"REEVESD","dateCreated":"2009-07-21","modifiedBy":"ONEDATA","dateModified":"2009-07-21","deletedIndicator":"No"},{"value":"0","valueDescription":"0 - CD4 cells > or = 200/microL","ValueMeaning":{"publicId":"2921059","version":"1","preferredName":"0 - CD4 cells > or = 200/microL","longName":"2921059","preferredDefinition":"CD4 cells more than or equal to 200/microLiter","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"6F363A70-C31C-668A-E040-BB89AD43602E","latestVersionIndicator":"Yes","beginDate":"2009-07-21","endDate":null,"createdBy":"REEVESD","dateCreated":"2009-07-21","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"6F363A70-C335-668A-E040-BB89AD43602E","beginDate":"2009-07-21","endDate":null,"createdBy":"REEVESD","dateCreated":"2009-07-21","modifiedBy":"ONEDATA","dateModified":"2009-07-21","deletedIndicator":"No"}],"ConceptualDomain":{"publicId":"2008549","version":"1","preferredName":"Involvement and Extent of Disease","preferredDefinition":"indication of the presence and extent of disease.","longName":"INV_AND_EXT_OF_DZ","context":"CTEP","contextVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B22AA815-A017-5261-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2002-12-19","endDate":null,"createdBy":"MSUPLEY","dateCreated":"2002-12-19","modifiedBy":"SBR","dateModified":"2003-10-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"RepresentationTerm":{"publicId":"2921056","version":"1","preferredName":"Acquired Immunodeficiency Syndrome Immune Stage","preferredDefinition":"A syndrome resulting from the acquired deficiency of cellular immunity caused by the human immunodeficiency virus (HIV). It is characterized by the reduction of the Helper T-lymphocytes in the peripheral blood and the lymph nodes; opportunistic infections (usually pneumocystis carinii pneumonia, cytomegalovirus (CMV) infections, tuberculosis, candida infections, and cryptococcosis); and the development of malignant neoplasms (usually non-Hodgkin's lymphoma and Kaposi's sarcoma). The human immunodeficiency virus is transmitted through sexual contact, sharing of contaminated needles, or transfusion of contaminated blood. Generalized lymphadenopathy, fever, weight loss, and chronic diarrhea are common symptoms of AIDS. The patients usually die either of opportunistic infections or malignant neoplasms. -- 2004:Protected against infectious disease by either specific or non-specific mechanisms. (On-line Medical Dictionary):The extent of a cancer within the body, especially whether the disease has spread from the original site to other parts of the body.","longName":"C2851:C17997:C16899","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Acquired Immunodeficiency Syndrome","conceptCode":"C2851","definition":"A syndrome resulting from the acquired deficiency of cellular immunity caused by the human immunodeficiency virus (HIV). It is characterized by the reduction of the Helper T-lymphocytes in the peripheral blood and the lymph nodes. Symptoms include generalized lymphadenopathy, fever, weight loss, and chronic diarrhea. Patients with AIDS are especially susceptible to opportunistic infections, tuberculosis, candida infections, and cryptococcosis), and the development of malignant neoplasms (usually non-Hodgkin lymphoma and Kaposi sarcoma). The human immunodeficiency virus is transmitted through sexual contact, sharing of contaminated needles, or transfusion of contaminated blood.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"2"},{"longName":"Immune","conceptCode":"C17997","definition":"Protected against infectious disease by either specific or non-specific mechanisms.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Neoplasm Stage","conceptCode":"C16899","definition":"The extent of a cancer in the body.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"6F363A70-C2D4-668A-E040-BB89AD43602E","latestVersionIndicator":"Yes","beginDate":"2009-07-21","endDate":null,"createdBy":"REEVESD","dateCreated":"2009-07-21","modifiedBy":"ONEDATA","dateModified":"2009-07-21","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"6F363A70-C2E5-668A-E040-BB89AD43602E","latestVersionIndicator":"Yes","beginDate":"2009-07-21","endDate":null,"createdBy":"REEVESD","dateCreated":"2009-07-21","modifiedBy":"SOKKERL","dateModified":"2017-05-26","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ClassificationSchemes":[{"publicId":"2008601","version":"1","longName":"C3D Domain","context":"CCR","ClassificationSchemeItems":[{"publicId":"2811685","version":"1","longName":"CCR","context":"CCR"}]},{"publicId":"2182125","version":"1","longName":"CCR Implementation","context":"CCR","ClassificationSchemeItems":[{"publicId":"2811673","version":"1","longName":"C3D","context":"CCR"}]}],"AlternateNames":[{"name":"Theradex","type":"USED_BY","context":"Theradex"}],"ReferenceDocuments":[{"name":"AIDS Immune (I) Stage","type":"Preferred Question Text","description":"AIDS Immune (I) Stage","url":null,"context":"CCR"},{"name":"Theradex - 1","type":"Alternate Question Text","description":"Immune Status","url":null,"context":"Theradex"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Qualified","id":"6F74F66D-0B47-6833-E040-BB89AD43171E","latestVersionIndicator":"Yes","beginDate":"2009-07-24","endDate":null,"createdBy":"REEVESD","dateCreated":"2009-07-24","modifiedBy":"SOKKERL","dateModified":"2017-05-26","changeDescription":"Curated for CCR Intramural trial.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"}}